| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Personality Disorders | 55 | 2022 | 172 | 8.180 |
Why?
|
| Mental Disorders | 56 | 2023 | 901 | 7.650 |
Why?
|
| Psychotherapy | 26 | 2021 | 245 | 6.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 30 | 2022 | 228 | 5.930 |
Why?
|
| Borderline Personality Disorder | 36 | 2022 | 159 | 5.710 |
Why?
|
| Psychiatry | 22 | 2021 | 272 | 5.420 |
Why?
|
| Mental Health Services | 10 | 2021 | 272 | 2.510 |
Why?
|
| Suicide | 9 | 2020 | 203 | 2.400 |
Why?
|
| Models, Psychological | 11 | 2017 | 141 | 2.180 |
Why?
|
| Personality | 10 | 2022 | 115 | 1.840 |
Why?
|
| Humans | 214 | 2024 | 131604 | 1.780 |
Why?
|
| Depressive Disorder | 11 | 2017 | 467 | 1.690 |
Why?
|
| Inpatients | 18 | 2022 | 545 | 1.640 |
Why?
|
| Psychiatric Status Rating Scales | 35 | 2018 | 844 | 1.610 |
Why?
|
| Telemedicine | 5 | 2021 | 519 | 1.540 |
Why?
|
| Firearms | 3 | 2022 | 58 | 1.460 |
Why?
|
| Evidence-Based Medicine | 10 | 2020 | 644 | 1.460 |
Why?
|
| Stress Disorders, Post-Traumatic | 8 | 2022 | 667 | 1.340 |
Why?
|
| Bipolar Disorder | 10 | 2018 | 364 | 1.280 |
Why?
|
| Psychoanalytic Therapy | 9 | 2014 | 11 | 1.170 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2020 | 79 | 1.120 |
Why?
|
| Hospitals, Psychiatric | 12 | 2022 | 70 | 1.110 |
Why?
|
| Personality Inventory | 11 | 2021 | 179 | 1.070 |
Why?
|
| Adaptation, Psychological | 5 | 2017 | 435 | 1.040 |
Why?
|
| Personality Assessment | 14 | 2015 | 112 | 1.010 |
Why?
|
| Aging | 3 | 2024 | 1264 | 0.970 |
Why?
|
| Advisory Committees | 4 | 2013 | 147 | 0.890 |
Why?
|
| Object Attachment | 4 | 2022 | 59 | 0.860 |
Why?
|
| Internet | 2 | 2020 | 419 | 0.840 |
Why?
|
| Hospitalization | 16 | 2020 | 1939 | 0.840 |
Why?
|
| Societies, Medical | 8 | 2017 | 794 | 0.840 |
Why?
|
| Sports | 1 | 2024 | 64 | 0.830 |
Why?
|
| Depression | 10 | 2024 | 1338 | 0.810 |
Why?
|
| Psychometrics | 17 | 2016 | 671 | 0.800 |
Why?
|
| Adult | 73 | 2022 | 31702 | 0.800 |
Why?
|
| Antipsychotic Agents | 6 | 2010 | 379 | 0.790 |
Why?
|
| Anticonvulsants | 5 | 2008 | 391 | 0.780 |
Why?
|
| Violence | 6 | 2013 | 128 | 0.780 |
Why?
|
| Interpersonal Relations | 10 | 2014 | 226 | 0.780 |
Why?
|
| Hallucinogens | 1 | 2023 | 59 | 0.740 |
Why?
|
| Happiness | 1 | 2022 | 12 | 0.740 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 102 | 0.690 |
Why?
|
| Resilience, Psychological | 2 | 2021 | 79 | 0.690 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 101 | 0.680 |
Why?
|
| Surveys and Questionnaires | 7 | 2022 | 4039 | 0.680 |
Why?
|
| Mind-Body Therapies | 2 | 2012 | 12 | 0.670 |
Why?
|
| Consensus | 2 | 2013 | 565 | 0.670 |
Why?
|
| Physician-Patient Relations | 5 | 2013 | 435 | 0.660 |
Why?
|
| Prescription Drug Misuse | 1 | 2020 | 8 | 0.630 |
Why?
|
| Communication | 4 | 2016 | 530 | 0.630 |
Why?
|
| Racism | 1 | 2020 | 43 | 0.620 |
Why?
|
| Pain | 2 | 2020 | 439 | 0.610 |
Why?
|
| Exercise Therapy | 1 | 2021 | 175 | 0.610 |
Why?
|
| Quality Indicators, Health Care | 3 | 2014 | 237 | 0.600 |
Why?
|
| Pedophilia | 1 | 2018 | 2 | 0.590 |
Why?
|
| Clergy | 1 | 2018 | 4 | 0.590 |
Why?
|
| Information Dissemination | 3 | 2017 | 195 | 0.580 |
Why?
|
| Family | 1 | 2022 | 589 | 0.570 |
Why?
|
| Health Education | 1 | 2020 | 229 | 0.560 |
Why?
|
| Minority Groups | 1 | 2020 | 256 | 0.560 |
Why?
|
| Emotions | 5 | 2018 | 361 | 0.560 |
Why?
|
| Pregnancy, Multiple | 1 | 2018 | 44 | 0.550 |
Why?
|
| Patient Rights | 2 | 2009 | 49 | 0.550 |
Why?
|
| Right to Die | 1 | 2017 | 2 | 0.540 |
Why?
|
| Polypharmacy | 2 | 2016 | 36 | 0.540 |
Why?
|
| Risk Management | 2 | 2017 | 66 | 0.540 |
Why?
|
| Psychotic Disorders | 4 | 2017 | 154 | 0.530 |
Why?
|
| Mental Health | 1 | 2021 | 382 | 0.530 |
Why?
|
| Male | 69 | 2022 | 65228 | 0.520 |
Why?
|
| Severity of Illness Index | 12 | 2017 | 3094 | 0.520 |
Why?
|
| Sleep | 1 | 2020 | 373 | 0.520 |
Why?
|
| United States | 25 | 2020 | 11800 | 0.520 |
Why?
|
| Substance-Related Disorders | 3 | 2019 | 493 | 0.510 |
Why?
|
| Human Trafficking | 1 | 2018 | 60 | 0.510 |
Why?
|
| Referral and Consultation | 4 | 2019 | 566 | 0.500 |
Why?
|
| Anxiety | 3 | 2020 | 1003 | 0.500 |
Why?
|
| Universities | 2 | 2007 | 122 | 0.500 |
Why?
|
| Self Concept | 4 | 2015 | 163 | 0.490 |
Why?
|
| Disasters | 1 | 2017 | 101 | 0.490 |
Why?
|
| Comorbidity | 20 | 2020 | 1595 | 0.490 |
Why?
|
| Self-Injurious Behavior | 2 | 2015 | 67 | 0.490 |
Why?
|
| Mandatory Programs | 1 | 2015 | 6 | 0.480 |
Why?
|
| Physician Impairment | 1 | 2015 | 10 | 0.480 |
Why?
|
| Attitude of Health Personnel | 5 | 2016 | 714 | 0.480 |
Why?
|
| Personal Narratives as Topic | 1 | 2015 | 2 | 0.470 |
Why?
|
| Trauma and Stressor Related Disorders | 1 | 2015 | 1 | 0.470 |
Why?
|
| Lawyers | 1 | 2015 | 5 | 0.470 |
Why?
|
| Ambulatory Care | 8 | 2015 | 407 | 0.460 |
Why?
|
| Psychotropic Drugs | 6 | 2011 | 123 | 0.460 |
Why?
|
| Health Status | 3 | 2015 | 387 | 0.460 |
Why?
|
| Theory of Mind | 1 | 2015 | 28 | 0.460 |
Why?
|
| Attitude to Death | 2 | 2017 | 38 | 0.460 |
Why?
|
| Terminology as Topic | 5 | 2015 | 227 | 0.460 |
Why?
|
| Suicidal Ideation | 7 | 2022 | 256 | 0.450 |
Why?
|
| Exercise | 1 | 2021 | 866 | 0.450 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2016 | 144 | 0.450 |
Why?
|
| Anxiety Disorders | 6 | 2019 | 716 | 0.450 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 470 | 0.440 |
Why?
|
| Middle Aged | 39 | 2019 | 28883 | 0.440 |
Why?
|
| Female | 68 | 2022 | 71145 | 0.440 |
Why?
|
| Research | 3 | 2009 | 266 | 0.440 |
Why?
|
| Early Diagnosis | 1 | 2015 | 192 | 0.430 |
Why?
|
| Personal Autonomy | 1 | 2015 | 206 | 0.420 |
Why?
|
| Affective Symptoms | 1 | 2014 | 62 | 0.420 |
Why?
|
| Pain Management | 1 | 2016 | 199 | 0.410 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 59 | 0.410 |
Why?
|
| Survivors | 2 | 2012 | 354 | 0.400 |
Why?
|
| Guideline Adherence | 2 | 2008 | 392 | 0.400 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 169 | 0.390 |
Why?
|
| Mass Casualty Incidents | 1 | 2013 | 17 | 0.390 |
Why?
|
| Insurance, Health | 1 | 2013 | 140 | 0.380 |
Why?
|
| Patient Care Management | 1 | 2013 | 61 | 0.380 |
Why?
|
| Social Change | 1 | 2012 | 15 | 0.380 |
Why?
|
| Anomie | 1 | 2012 | 1 | 0.370 |
Why?
|
| Military Personnel | 1 | 2014 | 209 | 0.360 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2012 | 5 | 0.360 |
Why?
|
| International Agencies | 1 | 2012 | 29 | 0.360 |
Why?
|
| Placebo Effect | 1 | 2011 | 20 | 0.360 |
Why?
|
| Emergency Responders | 1 | 2012 | 17 | 0.360 |
Why?
|
| Warfare | 1 | 2012 | 33 | 0.360 |
Why?
|
| Adolescent | 30 | 2018 | 20931 | 0.360 |
Why?
|
| Sex Characteristics | 1 | 2014 | 338 | 0.360 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 459 | 0.360 |
Why?
|
| Social Media | 1 | 2014 | 119 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 5 | 2008 | 1306 | 0.360 |
Why?
|
| Models, Theoretical | 2 | 2011 | 366 | 0.350 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 342 | 0.350 |
Why?
|
| Young Adult | 17 | 2020 | 10094 | 0.350 |
Why?
|
| Social Adjustment | 3 | 2015 | 79 | 0.350 |
Why?
|
| Dangerous Behavior | 3 | 2007 | 11 | 0.350 |
Why?
|
| Safety | 2 | 2022 | 215 | 0.350 |
Why?
|
| Medicine | 2 | 2009 | 102 | 0.340 |
Why?
|
| Occupational Diseases | 1 | 2012 | 78 | 0.340 |
Why?
|
| Cultural Competency | 1 | 2012 | 50 | 0.340 |
Why?
|
| Review Literature as Topic | 2 | 2008 | 52 | 0.340 |
Why?
|
| Bereavement | 1 | 2011 | 20 | 0.340 |
Why?
|
| Cooperative Behavior | 3 | 2021 | 223 | 0.340 |
Why?
|
| Life Change Events | 1 | 2011 | 63 | 0.330 |
Why?
|
| Professional-Patient Relations | 3 | 2022 | 93 | 0.310 |
Why?
|
| Behavior Therapy | 2 | 2010 | 272 | 0.310 |
Why?
|
| Mood Disorders | 4 | 2016 | 131 | 0.300 |
Why?
|
| Brain | 6 | 2021 | 3238 | 0.300 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 348 | 0.300 |
Why?
|
| Drug Monitoring | 2 | 2009 | 285 | 0.290 |
Why?
|
| Fear | 4 | 2020 | 198 | 0.290 |
Why?
|
| Longitudinal Studies | 10 | 2018 | 1516 | 0.290 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 332 | 0.290 |
Why?
|
| Reproducibility of Results | 11 | 2018 | 2986 | 0.290 |
Why?
|
| Spirituality | 1 | 2009 | 48 | 0.290 |
Why?
|
| Metformin | 1 | 2010 | 168 | 0.280 |
Why?
|
| Cognition | 1 | 2014 | 843 | 0.280 |
Why?
|
| Personality Development | 3 | 2011 | 15 | 0.280 |
Why?
|
| Drug Approval | 1 | 2008 | 45 | 0.280 |
Why?
|
| Factor Analysis, Statistical | 4 | 2016 | 235 | 0.270 |
Why?
|
| Medication Adherence | 1 | 2011 | 334 | 0.270 |
Why?
|
| Weight Gain | 1 | 2010 | 384 | 0.270 |
Why?
|
| Risperidone | 1 | 2008 | 61 | 0.270 |
Why?
|
| United States Food and Drug Administration | 1 | 2008 | 156 | 0.270 |
Why?
|
| Publishing | 1 | 2009 | 105 | 0.260 |
Why?
|
| Valproic Acid | 1 | 2008 | 161 | 0.260 |
Why?
|
| Homicide | 1 | 2007 | 34 | 0.260 |
Why?
|
| Veterans | 1 | 2019 | 1797 | 0.260 |
Why?
|
| Health Behavior | 1 | 2010 | 390 | 0.250 |
Why?
|
| Goals | 3 | 2021 | 125 | 0.250 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 363 | 0.250 |
Why?
|
| Remission Induction | 2 | 2018 | 309 | 0.250 |
Why?
|
| Community Mental Health Services | 1 | 2007 | 42 | 0.250 |
Why?
|
| Body Weight | 2 | 2010 | 990 | 0.250 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 475 | 0.250 |
Why?
|
| Risk Assessment | 5 | 2020 | 3695 | 0.240 |
Why?
|
| Schizotypal Personality Disorder | 3 | 2002 | 7 | 0.240 |
Why?
|
| Holistic Health | 1 | 2006 | 12 | 0.240 |
Why?
|
| Compulsive Personality Disorder | 3 | 2002 | 16 | 0.240 |
Why?
|
| Health Promotion | 1 | 2009 | 407 | 0.230 |
Why?
|
| Child Abuse | 2 | 2001 | 222 | 0.230 |
Why?
|
| Interview, Psychological | 4 | 2014 | 104 | 0.230 |
Why?
|
| Quality of Life | 1 | 2015 | 2113 | 0.220 |
Why?
|
| Students | 1 | 2007 | 251 | 0.220 |
Why?
|
| Cultural Diversity | 1 | 2005 | 78 | 0.220 |
Why?
|
| New York | 6 | 2008 | 69 | 0.220 |
Why?
|
| Terrorism | 1 | 2004 | 4 | 0.210 |
Why?
|
| Athletes | 1 | 2024 | 73 | 0.210 |
Why?
|
| Crisis Intervention | 2 | 2021 | 4 | 0.200 |
Why?
|
| Awareness | 1 | 2004 | 81 | 0.200 |
Why?
|
| Social Support | 3 | 2009 | 374 | 0.200 |
Why?
|
| Suicide, Attempted | 3 | 2020 | 153 | 0.200 |
Why?
|
| Schizophrenia | 2 | 2006 | 331 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2022 | 562 | 0.180 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2021 | 11 | 0.180 |
Why?
|
| Motivation | 2 | 2022 | 334 | 0.180 |
Why?
|
| Treatment Outcome | 12 | 2019 | 12964 | 0.180 |
Why?
|
| Time Factors | 7 | 2019 | 6279 | 0.180 |
Why?
|
| Diagnosis, Differential | 6 | 2018 | 1911 | 0.180 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 43 | 0.170 |
Why?
|
| Combined Modality Therapy | 5 | 2016 | 1258 | 0.170 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 2016 | 13 | 0.170 |
Why?
|
| Psychotherapy, Brief | 1 | 2021 | 52 | 0.170 |
Why?
|
| Group Processes | 1 | 2021 | 48 | 0.170 |
Why?
|
| Prevalence | 9 | 2014 | 2694 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2004 | 775 | 0.170 |
Why?
|
| Prognosis | 6 | 2018 | 4952 | 0.160 |
Why?
|
| Health Services Accessibility | 3 | 2019 | 696 | 0.160 |
Why?
|
| Disability Evaluation | 2 | 2018 | 197 | 0.160 |
Why?
|
| Cyclohexanecarboxylic Acids | 3 | 2008 | 18 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2020 | 6494 | 0.160 |
Why?
|
| Smartphone | 1 | 2020 | 46 | 0.160 |
Why?
|
| Amines | 3 | 2008 | 37 | 0.160 |
Why?
|
| Research Design | 4 | 2009 | 722 | 0.160 |
Why?
|
| Human Experimentation | 1 | 1999 | 32 | 0.150 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 409 | 0.150 |
Why?
|
| Temporal Lobe | 1 | 2020 | 116 | 0.150 |
Why?
|
| Piperazines | 2 | 2007 | 272 | 0.150 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2011 | 45 | 0.150 |
Why?
|
| Self Report | 3 | 2018 | 558 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2008 | 179 | 0.140 |
Why?
|
| Politics | 2 | 2017 | 59 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 3917 | 0.140 |
Why?
|
| Mobile Applications | 1 | 2020 | 114 | 0.140 |
Why?
|
| ROC Curve | 3 | 2018 | 615 | 0.140 |
Why?
|
| Bioethics | 1 | 1999 | 81 | 0.140 |
Why?
|
| Virginia | 2 | 2007 | 21 | 0.130 |
Why?
|
| Dependent Personality Disorder | 2 | 1996 | 2 | 0.130 |
Why?
|
| Empathy | 1 | 2017 | 66 | 0.130 |
Why?
|
| Coercion | 1 | 2017 | 26 | 0.130 |
Why?
|
| Quality of Health Care | 2 | 2014 | 411 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2017 | 492 | 0.130 |
Why?
|
| Decision Making | 2 | 2013 | 683 | 0.120 |
Why?
|
| Odds Ratio | 5 | 2007 | 1235 | 0.120 |
Why?
|
| Drug Interactions | 2 | 2008 | 241 | 0.120 |
Why?
|
| Somatoform Disorders | 1 | 2016 | 46 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2020 | 869 | 0.120 |
Why?
|
| Individuality | 1 | 2015 | 38 | 0.120 |
Why?
|
| Utilization Review | 2 | 2007 | 40 | 0.120 |
Why?
|
| Affect | 2 | 2009 | 170 | 0.120 |
Why?
|
| Placebos | 3 | 2011 | 227 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2005 | 1215 | 0.110 |
Why?
|
| Child | 9 | 2018 | 26250 | 0.110 |
Why?
|
| Neurotic Disorders | 1 | 2014 | 6 | 0.110 |
Why?
|
| Anniversaries and Special Events | 1 | 2014 | 10 | 0.110 |
Why?
|
| Disease Progression | 2 | 2018 | 2206 | 0.110 |
Why?
|
| Personality Tests | 1 | 2014 | 17 | 0.110 |
Why?
|
| Emergency Services, Psychiatric | 1 | 1995 | 23 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2017 | 389 | 0.110 |
Why?
|
| Hostility | 1 | 2014 | 21 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 2297 | 0.110 |
Why?
|
| Medical Staff | 1 | 2014 | 6 | 0.110 |
Why?
|
| Patient Admission | 2 | 2012 | 184 | 0.110 |
Why?
|
| Impulsive Behavior | 2 | 2020 | 162 | 0.110 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2014 | 34 | 0.110 |
Why?
|
| Receptors, Serotonin | 1 | 1994 | 37 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 996 | 0.100 |
Why?
|
| Legislation as Topic | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cross-Sectional Studies | 5 | 2016 | 3834 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 153 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2014 | 244 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 432 | 0.100 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2013 | 7 | 0.100 |
Why?
|
| Pandemics | 1 | 2021 | 1161 | 0.100 |
Why?
|
| Psychophysiology | 1 | 2013 | 9 | 0.100 |
Why?
|
| Serotonin | 1 | 1994 | 212 | 0.100 |
Why?
|
| Video Games | 1 | 2014 | 97 | 0.100 |
Why?
|
| Cognition Disorders | 2 | 2009 | 565 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2016 | 376 | 0.090 |
Why?
|
| Motivational Interviewing | 1 | 2013 | 51 | 0.090 |
Why?
|
| History, 21st Century | 2 | 2014 | 263 | 0.090 |
Why?
|
| Administrative Personnel | 1 | 2012 | 26 | 0.090 |
Why?
|
| Financing, Government | 1 | 2012 | 32 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2014 | 366 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 835 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 564 | 0.090 |
Why?
|
| Aged | 7 | 2015 | 21255 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2020 | 17666 | 0.080 |
Why?
|
| Societies, Scientific | 1 | 2010 | 24 | 0.080 |
Why?
|
| Age of Onset | 2 | 2011 | 632 | 0.080 |
Why?
|
| Relaxation Therapy | 1 | 2010 | 22 | 0.080 |
Why?
|
| Ego | 1 | 2010 | 10 | 0.080 |
Why?
|
| Social Stigma | 1 | 2011 | 82 | 0.080 |
Why?
|
| Patient Participation | 1 | 2013 | 244 | 0.080 |
Why?
|
| Narcissism | 1 | 2009 | 7 | 0.080 |
Why?
|
| Military Psychiatry | 1 | 2009 | 1 | 0.080 |
Why?
|
| Prazosin | 1 | 2009 | 16 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2013 | 469 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 40 | 0.080 |
Why?
|
| Age Factors | 4 | 2017 | 2872 | 0.080 |
Why?
|
| Terminal Care | 1 | 2011 | 114 | 0.080 |
Why?
|
| Trust | 1 | 2010 | 81 | 0.080 |
Why?
|
| Psychology, Clinical | 1 | 2009 | 4 | 0.080 |
Why?
|
| Risk Factors | 6 | 2020 | 10959 | 0.080 |
Why?
|
| Health Care Reform | 1 | 2009 | 52 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2009 | 83 | 0.070 |
Why?
|
| Implosive Therapy | 1 | 2010 | 98 | 0.070 |
Why?
|
| Drug Evaluation | 1 | 2008 | 102 | 0.070 |
Why?
|
| Social Marketing | 1 | 2008 | 9 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2014 | 707 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2008 | 44 | 0.070 |
Why?
|
| Psychotherapeutic Processes | 1 | 2007 | 4 | 0.070 |
Why?
|
| Reimbursement, Incentive | 1 | 2008 | 48 | 0.070 |
Why?
|
| Aripiprazole | 1 | 2007 | 23 | 0.070 |
Why?
|
| Haloperidol | 1 | 2007 | 22 | 0.070 |
Why?
|
| Neurosciences | 1 | 2007 | 48 | 0.060 |
Why?
|
| Aggression | 1 | 2009 | 221 | 0.060 |
Why?
|
| Quinolones | 1 | 2007 | 58 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2011 | 557 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2009 | 5296 | 0.060 |
Why?
|
| Forecasting | 2 | 2009 | 361 | 0.060 |
Why?
|
| Freudian Theory | 1 | 2006 | 1 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 152 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2012 | 684 | 0.060 |
Why?
|
| Bulimia | 3 | 1996 | 16 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2006 | 110 | 0.060 |
Why?
|
| Therapeutic Community | 2 | 1983 | 2 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2007 | 164 | 0.060 |
Why?
|
| Texas | 1 | 2014 | 3615 | 0.060 |
Why?
|
| Cultural Characteristics | 1 | 2005 | 44 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 310 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2009 | 390 | 0.060 |
Why?
|
| Pregnancy | 1 | 2018 | 7572 | 0.060 |
Why?
|
| Institutionalization | 1 | 2005 | 13 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 726 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2001 | 998 | 0.050 |
Why?
|
| New York City | 1 | 2004 | 64 | 0.050 |
Why?
|
| Social Isolation | 1 | 1983 | 43 | 0.050 |
Why?
|
| Language | 1 | 2005 | 218 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2004 | 1234 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1255 | 0.050 |
Why?
|
| Clinical Clerkship | 1 | 1983 | 72 | 0.050 |
Why?
|
| Patient Discharge | 2 | 2020 | 506 | 0.050 |
Why?
|
| Algorithms | 2 | 2018 | 1686 | 0.050 |
Why?
|
| Antisocial Personality Disorder | 1 | 2022 | 65 | 0.040 |
Why?
|
| Family Practice | 1 | 2002 | 88 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2005 | 291 | 0.040 |
Why?
|
| North America | 1 | 2002 | 256 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1983 | 173 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2008 | 1052 | 0.040 |
Why?
|
| Chest Pain | 1 | 2001 | 125 | 0.040 |
Why?
|
| Crime | 1 | 2000 | 26 | 0.040 |
Why?
|
| Benchmarking | 1 | 2001 | 138 | 0.040 |
Why?
|
| Reward | 1 | 2021 | 117 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 3 | 2009 | 58 | 0.040 |
Why?
|
| Learning | 1 | 1983 | 369 | 0.040 |
Why?
|
| Curriculum | 1 | 2005 | 783 | 0.040 |
Why?
|
| Risk | 2 | 2001 | 739 | 0.040 |
Why?
|
| Stereotyping | 1 | 1999 | 19 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2006 | 787 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2007 | 5123 | 0.040 |
Why?
|
| Human Rights | 1 | 1999 | 24 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2019 | 11 | 0.040 |
Why?
|
| Phenotype | 1 | 2009 | 4516 | 0.040 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2019 | 32 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3454 | 0.040 |
Why?
|
| Students, Medical | 1 | 1983 | 350 | 0.040 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2019 | 49 | 0.040 |
Why?
|
| Biomarkers | 1 | 2008 | 3405 | 0.040 |
Why?
|
| Anorexia Nervosa | 2 | 1996 | 31 | 0.040 |
Why?
|
| Aftercare | 1 | 2020 | 154 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 386 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 200 | 0.030 |
Why?
|
| Self-Control | 1 | 2017 | 17 | 0.030 |
Why?
|
| Rest | 1 | 2017 | 63 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 752 | 0.030 |
Why?
|
| Electronics | 1 | 2015 | 45 | 0.030 |
Why?
|
| Bed Occupancy | 1 | 1995 | 3 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2017 | 285 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2000 | 2143 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1346 | 0.030 |
Why?
|
| Biomedical Technology | 1 | 2015 | 39 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 1995 | 31 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2015 | 1075 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1995 | 272 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 570 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 825 | 0.030 |
Why?
|
| Adolescent, Hospitalized | 1 | 2014 | 7 | 0.030 |
Why?
|
| Depersonalization | 1 | 1994 | 9 | 0.030 |
Why?
|
| Anger | 1 | 1994 | 28 | 0.030 |
Why?
|
| Prolactin | 1 | 1994 | 112 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 130 | 0.030 |
Why?
|
| Alcoholism | 1 | 1996 | 246 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 695 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2013 | 23 | 0.020 |
Why?
|
| Feeding and Eating Disorders | 1 | 1993 | 74 | 0.020 |
Why?
|
| Beneficence | 1 | 2013 | 85 | 0.020 |
Why?
|
| Patient Simulation | 1 | 2013 | 40 | 0.020 |
Why?
|
| Communication Barriers | 1 | 2013 | 40 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2012 | 28 | 0.020 |
Why?
|
| Cost Control | 1 | 2012 | 23 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2005 | 773 | 0.020 |
Why?
|
| Criminal Law | 1 | 2012 | 15 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 36 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1994 | 709 | 0.020 |
Why?
|
| Hospitals, State | 1 | 1991 | 3 | 0.020 |
Why?
|
| Australia | 2 | 2002 | 176 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2012 | 59 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1996 | 1453 | 0.020 |
Why?
|
| Social Environment | 1 | 1992 | 122 | 0.020 |
Why?
|
| Canada | 2 | 2002 | 327 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 143 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 2013 | 399 | 0.020 |
Why?
|
| Netherlands | 1 | 2009 | 55 | 0.020 |
Why?
|
| Informatics | 1 | 2009 | 7 | 0.020 |
Why?
|
| Capital Financing | 1 | 2009 | 7 | 0.020 |
Why?
|
| Medical Laboratory Science | 1 | 2009 | 12 | 0.020 |
Why?
|
| Social Behavior | 1 | 2011 | 217 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 1153 | 0.020 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2008 | 12 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2008 | 65 | 0.020 |
Why?
|
| Sex Distribution | 2 | 2001 | 322 | 0.020 |
Why?
|
| Health Policy | 1 | 2009 | 227 | 0.020 |
Why?
|
| Logistic Models | 2 | 2001 | 1831 | 0.010 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2008 | 267 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2001 | 15054 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2000 | 501 | 0.010 |
Why?
|
| Periodicity | 1 | 1983 | 49 | 0.010 |
Why?
|
| Patient Advocacy | 1 | 1983 | 60 | 0.010 |
Why?
|
| Incidence | 1 | 1991 | 3347 | 0.010 |
Why?
|
| Attitude | 1 | 1983 | 111 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 210 | 0.010 |
Why?
|
| Teaching | 1 | 1983 | 195 | 0.010 |
Why?
|
| New England | 1 | 2001 | 11 | 0.010 |
Why?
|
| Problem Solving | 1 | 1982 | 65 | 0.010 |
Why?
|
| England | 1 | 2001 | 58 | 0.010 |
Why?
|
| Day Care, Medical | 1 | 2001 | 11 | 0.010 |
Why?
|
| Self-Help Groups | 1 | 2001 | 14 | 0.010 |
Why?
|
| Educational Measurement | 1 | 1983 | 317 | 0.010 |
Why?
|
| Psychology, Adolescent | 1 | 2000 | 35 | 0.010 |
Why?
|
| Age Distribution | 1 | 2001 | 429 | 0.010 |
Why?
|
| New South Wales | 1 | 2000 | 12 | 0.010 |
Why?
|
| New Zealand | 1 | 2000 | 58 | 0.010 |
Why?
|
| Data Collection | 1 | 2002 | 371 | 0.010 |
Why?
|
| Observer Variation | 1 | 2000 | 319 | 0.010 |
Why?
|
| Heart Rate | 1 | 2001 | 580 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 34371 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1999 | 418 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 1521 | 0.010 |
Why?
|
| Manuals as Topic | 2 | 1988 | 10 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2001 | 1344 | 0.010 |
Why?
|
| Phobic Disorders | 1 | 1995 | 40 | 0.010 |
Why?
|
| Desipramine | 1 | 1992 | 26 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1992 | 88 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1992 | 142 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1992 | 1634 | 0.000 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1995 | 856 | 0.000 |
Why?
|